InPhamed empowers pharmaceutical companies, clinical research organizations, and API manufacturers with essential data and actionable intelligence. Our expertise spans intellectual property, clinical trials, drug treatments, regulatory landscapes, and commercial markets.
Read more
Build your drug portfolio for successful generic Launches in US, Europe and ROW markets
Encompasses a wide range of therapeutic areas, each with its own unique challenges and opportunities.
Identify when a drug will lose exclusivity and exact date of generic launch in US and EU
Identify and partner with an API supplier for your next generic launch
Monitor and track 505(B2) activity, potential new dosage, formulation, and indication for marketed drugs